Control subjects
(n = 230)
Extremely obese patients
(n = 335)
p value
Age [years] 49.90 ± 16.30 54.13 ± 11.98 < 0.001
Male/female  [%] 33.91 / 66.09 35.22 / 64.78    0.955
BMI [kg/m2] 24.04 ± 2.33 44.82 ± 5.51 < 0.001
WHR: Women 0.7971 ± 0.0787 0.9475 ± 0.0720 < 0.001
WHR: Men 0.9063 ± 0.0875 1.0217 ± 0.0613 < 0.001
Hypertension [%] 33.33 88.89 < 0.001
SBP [mm Hg] 115.60 ± 26.53 123.67 ± 8.86 < 0.001
DBP [mm Hg] 70.72 ± 21.32 78.52 ± 3.95 < 0.001
Fasting glucose [mg/dL] 95.37 ± 12.84 120.90 ± 33.05 < 0.001
T2DM % 0 60.00 < 0.001
TC [mg/dL] 207.45 ± 46.38 203.39 ± 57.23    <0.05
LDL-C [mg/dL] 124.39 ± 40.52 117.00 ± 43.12    <0.05
HDL-C [mg/dL] 63.14 ± 17.58 52.93 ± 16.65 < 0.001
TG [mg/dL] 110.72 ± 66.54 153.02± 75.27 < 0.001
Data are presented as mean ± SD (standard deviation), BMI: Body Mass Index;WHR: Waist To Hip Ratio; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; T2DM: Type 2 Diabetes Mellitus; TC: Total Cholesterol; LDL-C: Low-Density Lipoproteins; HDL-C: High-Density Lipoproteins; TG: Triglicerydes.
Table 1: Clinical and biochemical characteristics of the extremely obese patients and control subjects.